New insights into Parkinson's disease

Super-resolution microscopy tech was used to track the tipping point in Parkinson's disease; the change in chemistry in the brain that triggers the disease. And the researchers at the University of Cambridge concluded that the same protein evidently can either protect or spur the toxic effects in the brain that kills brain cells, depending on the form it takes. Release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.